Live feed11:18:00·13mPRReleasevia QuantisnowLEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer’s Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of TreatmentByQuantisnow·Wall Street's wire, on your screen.BIIB· Biogen Inc.Health Care
